Tofacinib for JIA A3921145
|Clinical Trial Title||Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis|
|Trial Status||Open to Enrollment|
|Trial Type||Pediatric Rheumatology|
|Specific Condition||Juvenile Idiopathic Arthritis|
This study is being done to examine the long-term safety and efficacy of an investigational drug (CP-690,550) in children with Juvenile Idiopathic Arthritis (JIA). This is an extension of a previous treatment study and subjects can only participate if they were in the previous study.
Subjects will be in this study for up to 10 years. The total duration of an individual subject’s participation may vary depending upon when they entered the trial.
Subjects will receive the medication in either liquid or tablet form, depending on his/her age and weight.
|Principal Investigator||Daniel Kingsbury, MD|
|Contact Name||Kristin Hickey|